EXECUTIVE EMPLOYMENT AGREEMENTRestrictive Covenant Agreement • October 31st, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • Maine
THIS THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made as of August 2, 2024 (the “Effective Date”) by and between IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), and Jonathan (Jay) Mazelsky (the “Executive”) and amends and restates in its entirety the Second Amended and Restated Employment Agreement by and between the Company and the Executive dated as of October 23, 2019.
FORM OF CHANGE IN CONTROL AGREEMENTChange in Control Agreement • October 31st, 2024 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS CHANGE IN CONTROL AGREEMENT is made as of [ ], 20[ ] (this “Agreement”), by and between IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), and (the “Executive”) [and amends and restates in its entirety the [Amended and Restated] Executive Employment Agreement by and between the Company and the Executive dated as of [ ]].
